H3.3K27M mutant proteins reprogram epigenome by sequestering the PRC2 complex to poised enhancers

Area of Science:

• Oncology
• Epigenetics
• Molecular Biology

Background:

• Diffuse intrinsic pontine glioma (DIPG) is a pediatric brain tumor characterized by histone H3.3K27M mutations.
• These mutations lead to a global decrease in H3K27 trimethylation (H3K27me3), a key epigenetic mark, yet paradoxically, some H3K27me3 peaks persist.

Purpose of the Study:

• To elucidate the mechanistic basis for the dichotomous changes in H3K27me3 levels in H3.3K27M mutant DIPG.
• To understand how PRC2 complex localization and activity are affected by H3.3K27M mutations.

Main Methods:

• Chromatin immunoprecipitation (ChIP) assays to assess H3K27me3 and PRC2 occupancy at genomic loci.
• Analysis of H3.3K27M protein levels across different genomic regions.

Main Results:

• PRC2 complex is sequestered at poised enhancers, not active promoters, in the presence of high H3.3K27M levels, explaining global H3K27me3 reduction.
• Retained H3K27me3 peaks show low H3.3K27M levels, indicating minimal impact on PRC2 activity at these specific sites.
• H3K27me3-mediated silencing of tumor suppressor genes, such as Wilms Tumor 1, was observed, promoting DIPG cell proliferation.

Conclusions:

• H3.3K27M mutations redistribute the PRC2 complex to poised enhancers.
• This redistribution contributes to DIPG tumorigenesis by locally enhancing H3K27me3 and silencing tumor suppressor genes.